|1||Active, not recruiting||
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Exercise and Post-dry Needling Soreness
Brief Therapies for Problem Gambling Substance Abusers
Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software
Does Sugared or Sugar Free Chewing Gum Reduces Postoperative Ileus After Laparoscopic Cholecystectomy
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
The Dementia Quality of Life Scale for Older Family Carers (DQoL-OC) Study
Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants
Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
|11||Active, not recruiting||
Acceptance and Commitment Therapy and Cognitive Behavioral Therapy for Chronic Pain
† Study has passed its completion date and status has not been verified in more than two years.